Quiver Lobbying Spending Growth
This strategy takes an equal-weighted position in 10 publicly-traded companies that disclosed the most Quarter over Quarter growth in U.S. federal lobbying expenditures
Fund
516.87%
vs
Benchmark
165.36%
*Vertical reference line denotes the end of simulated backtest data and the start of live performance data.
** Performance data is calculated using the average returns of all accounts with more than $100 invested in this strategy.
Fund Holdings
Fund details
Stats
3.52/5
Risk score
Max draw down (of range)
Daily Sharpe (of range)
Daily Volatility (of range)
Monthly Volatility (of range)
76.00%
Correlation to S&P (total)
Description
The Lobbying Disclosure Act of 1995 requires lobbyists in the United States to disclose information about their activities, such as their clients, which issues they are lobbying on, and how much they are being paid. This data is scrapped and mapped to stock tickers to track which companies are spending money for legislative influence. Focusing on companies with a sudden increase in lobbying expenditures has historically been able to identify companies poised to benefit from favorable legislation and deliver excess returns. This portfolio is rebalanced at the start of every month.
Key Considerations
We use a rolling window for lobbying disclosures in an attempt to capture the full quarter’s lobbying expenditure. Large lobbying disclosures for a company on the same issue are often done quarterly with a semi-consistent interval, so there is potential for a company to move out of the rankings for one (or more) rebalance periods if the two disclosures are spread out, and conversely for a company to move into the ranking during a rebalance window if the two disclosures are closer together.
Lobbying disclosures are filed under a company’s legal name, and are not mapped to tickers at the source. Because of this, there is a risk of mapping lobbying disclosures to the wrong company, or missing disclosures that are filed under a subsidiary or other name. While we have taken steps to mitigate this risk, it presents the possibility for erroneous data.